Fragmin 25,000 units/mL Vial 76 mL per 30 days Fragmin 7,500 units/0.3 mL Syringe 6 mL
per 30 days Lovenox 30 mg/0.3 mL Syringe 8.4 mL per 28 days Lovenox 40 mg/0.4 mL …

Heparin is the anticoagulant of choice when a rapid anticoagulant effect is required because
its onset of action is immediate when administered by IV injection. Heparin is administered …

The literature does not consistently support the importance of anticoagulation monitoring
techniques during CPB. This is best reflected by studies that have evaluated the impact of …

Heparin is the anticoagulant of choice when a rapid anticoagulant effect is required because
its onset of action is immediate when administered by intravenous injection. Heparin is …

Heparin is normally used for anticoagulation during cardiopulmonary bypass (CPB), but its
use is contraindicated in patients with a history of heparin-induced thrombocytopenia …

Taking stock of advances in clinical recognition, laboratory testing, and pharmacologic
therapy as well as basic aspects of pathogenesis, the Third Edition of Heparin-Induced …

BACKGROUND.: In patients with heparin-induced thrombocytopenia undergoing cardiac
operations, anticoagulation with heparin should be avoided. The low-molecular-weight …

INTRODUCTION When a diagnosis of heparin-induced thrombocytopenia (HIT) is made,
cessation of heparin is mandatory. Thereafter, an alternative anticoagulant is usually …

Org 10172 provided adequate anticoagulation for this patient. An excellent correlation
between anti-factor Xa activity and ACT was observed at the doses used for CPB. If high …

This second edition ofAdvanced Therapy in Cardiac Surgerypresents state-of-the-art
techniques and an in-depth review of cardiac surgery from the leading authorities. Each of …